New national registry aims to improve care for rare genetic polyposis syndromes

NCT ID NCT07461246

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is a national registry collecting data from 1500 people with familial adenomatous polyposis (FAP) and related conditions across 28 Italian centers. It aims to better understand how these diseases progress, how they are currently managed, and what factors influence outcomes. No new treatments are being tested; instead, the registry will help improve future care guidelines and support research.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this registry could provide better guidelines for managing polyposis syndromes and improve early detection and treatment strategies.
What could go wrong
This is an observational study, not a clinical trial testing a new treatment. It collects data only, so no direct benefit to participants is expected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATTENUATED FAMILIAL ADENOMATOUS POLYPOSIS (AFAP) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fondazione IRCCS Istituto Nazionale dei Tumori

    Milan, 20133, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.